key: cord-0981848-jxq6f7xh
authors: Heffernan, Kevin S.; Young Jae, Sae
title: Exercise as medicine for COVID-19: an ACE in the hole?
date: 2020-05-12
journal: Med Hypotheses
DOI: 10.1016/j.mehy.2020.109835
sha: 4c4171b6449854b0683029453ce05f7f772ddd24
doc_id: 981848
cord_uid: jxq6f7xh

nan

The COVID-19 pandemic is currently exacerbating another established global pandemicphysical inactivity. (1) The World Health Organization attributes approximately 3.2 million deaths per year to sedentary behavior. For many, social distancing and quarantine coupled with the systemic closure of fitness centers and public parks have imposed unique structural barriers to maintaining a physically active lifestyle. From a public health perspective, the importance of not conflating shelter-in-place with staying-in-place needs to be reinforced. Herein, exercise will be discussed as a possible therapeutic strategy to bolster resilience against COVID-19 via effects on ACE2.

Since the angiotensin converting enzyme-2 (ACE2) receptor has been acknowledged as an important cellular entry point for SARS-CoV-2, controversy has ensued regarding use of angiotensin-converting enzyme inhibitors (ACEi) and angiotensin II receptor blockers (ARBs) in the management of COVID-19 patients with hypertension. Animal studies suggest that ACEi/ARBs may upregulate expression of ACE2 receptors. As such, concern arose that use of ACEi/ARBs by hypertensives might increase risk for developing COVID-19, exacerbate severity of COVID-19 morbidity and lead to increased fatal events with some further advocating for ACE2 blockade (or angiotensin II administration) as a potential strategy to mitigate viral entry of SARS-CoV-2 into ACE2 expressing cells. ACE2 via the production of Angiotensin 1-7 has anti-inflammatory and antifibrotic effects via the Mas receptor. Thus, the ACE2-Ang1-7-Mas receptor axis and the ACE-Ang II-AT1 receptor pathway may be viewed as two opposing yet complementary pathways; a duality whose balance is needed for optimal health. The binding of COVID-19 to the ACE2 binding site downregulates ACE2 and thus the ACE2-Ang1-7-Mas receptor axis, essentially over-activating the ACE-Ang II-AT1 receptor pathway. With less ACE2 available to convert angiotensin to Ang1-leading to a heightened inflammatory milieu and lung injury. At a time when many individuals are choosing to move less, the message that exercise is medicine is needed more. Exercise may be an ACE in the hole to help lower risk of COVID-19 infection and minimize the cardiopulmonary sequela during recovery.

We have no conflicts of interest to disclose.

A tale of two pandemics: How will COVID-19 and global trends in physical inactivity and sedentary behavior affect one another?

Covid-19 infection and mortality -A physiologist's perspective enlightening clinical features and plausible interventional strategies

Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics

Angiotensin converting enzyme 2 abrogates bleomycin-induced lung injury

Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19

Angiotensin-converting enzyme 2 in severe acute respiratory syndrome coronavirus and SARS-CoV-2: A double-edged sword?

Mas Receptor Axis of the Renin Angiotensin System

Original Research: ACE2 activator associated with physical exercise potentiates the reduction of pulmonary fibrosis